USD 7.57
(5.73%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 11.78 Million USD | -20.6% |
2022 | 14.84 Million USD | -10.64% |
2021 | 16.61 Million USD | 117.07% |
2020 | 7.65 Million USD | -42.87% |
2019 | 13.39 Million USD | 0.0% |
2018 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | 9.09 Million USD | -8.91% |
2024 Q1 | 10.89 Million USD | -7.57% |
2024 Q2 | 9.98 Million USD | -8.32% |
2023 Q1 | 13.86 Million USD | -6.62% |
2023 FY | 11.78 Million USD | -20.6% |
2023 Q4 | 11.78 Million USD | -5.62% |
2023 Q3 | 12.48 Million USD | -3.4% |
2023 Q2 | 12.92 Million USD | -6.74% |
2022 Q2 | 16.01 Million USD | -2.22% |
2022 Q1 | 16.38 Million USD | -1.4% |
2022 FY | 14.84 Million USD | -10.64% |
2022 Q4 | 14.84 Million USD | -6.23% |
2022 Q3 | 15.83 Million USD | -1.16% |
2021 FY | 16.61 Million USD | 117.07% |
2021 Q4 | 16.61 Million USD | -8.27% |
2021 Q3 | 18.1 Million USD | 326.4% |
2021 Q2 | 4.24 Million USD | -28.03% |
2021 Q1 | 5.9 Million USD | -22.89% |
2020 Q1 | 5.64 Million USD | -57.83% |
2020 Q4 | 7.65 Million USD | -18.39% |
2020 Q3 | 9.37 Million USD | -8.07% |
2020 Q2 | 10.2 Million USD | 80.56% |
2020 FY | 7.65 Million USD | -42.87% |
2019 FY | 13.39 Million USD | 0.0% |
2019 Q4 | 13.39 Million USD | 0.0% |
2018 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Doximity, Inc. | 14.54 Million USD | 18.974% |
Evolent Health, Inc. | 644.79 Million USD | 98.172% |
MultiPlan Corporation | 4.56 Billion USD | 99.742% |
Phreesia, Inc. | 11.98 Million USD | 1.644% |
Teladoc Health, Inc. | 1.59 Billion USD | 99.26% |
Veeva Systems Inc. | 55.77 Million USD | 78.869% |